vaccine

Featured

Travel and Leisure ETFs Surge Amid Positive Jobs Data

By Ian YoungNovember 5, 2021

Featured

Biotech ETFs Benefit From Moderna Dual Booster Shot News

By Ian YoungSeptember 9, 2021

Featured

Could Biotech ETFs Get Another Boost From JNJ News?

By Ian YoungAugust 26, 2021

Nasdaq Investment Intelligence Channel

Pfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approval

By Karrie GordonAugust 24, 2021

Featured

Crude ETFs Surge on Monday, Breaking Their Seven-Day Drop

By Ian YoungAugust 23, 2021

Nasdaq Investment Intelligence Channel

‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with Boosters

By Karrie GordonAugust 13, 2021

Innovative ETFs Channel

An ETF to Watch for Amidst the Vaccine Push

By Ben HernandezAugust 6, 2021

Featured

New CDC Covid-19 Guidance Spooks Stocks While Boosting Inverse Stock ETFs

By Ian YoungJuly 27, 2021

Featured

Stock ETFs Hit Fresh Highs Thursday

By Ian YoungApril 15, 2021

Thematic Investing Channel

With COVID Still Front and Center, WFH Stocks and ‘CLOU’ Keep Climbing

By Ben HernandezApril 15, 2021

Featured

Crude ETFs Surge Thanks to a New Report, OPEC Projections

By Ian YoungApril 14, 2021

Featured

Stock ETFs Score Fresh Highs Amid Bank Earnings

By Ian YoungApril 14, 2021

Featured

Stock ETFs Target Weekly Gains on Positive Economic Data

By Ian YoungMarch 26, 2021

Featured

Stock ETFs Attempt to Recover after Tuesday’s Sell-Off

By Ian YoungMarch 24, 2021

Featured

New Pfizer Covid Pill Could Be a Gamechanger for Biotech ETFs

By Ian YoungMarch 24, 2021

Featured

One Year after the Covid Crash, Stock ETFs Largely Uneventful

By Ian YoungMarch 23, 2021

Featured

Stock ETFs Climb to Start the New Week

By Ian YoungMarch 22, 2021

Featured

Stock ETFs Languish as Investors Eagerly Await Powell

By Ian YoungMarch 17, 2021